Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial.

@article{Vranckx2014ProspectiveVO,
  title={Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial.},
  author={Pascal Vranckx and Sergio Leonardi and Matteo Tebaldi and Simone Biscaglia and Giovanni Parrinello and Sunil V. Rao and Roxana Mehran and Marco Valgimigli},
  journal={European heart journal},
  year={2014},
  volume={35 37},
  pages={2524-9}
}
AIMS The Bleeding Academic Research Consortium (BARC) classification has been proposed by consensus to standardize bleeding endpoint definition and reporting in cardiovascular clinical trials. There are no prospective studies on its prognostic impact. METHODS AND RESULTS We explored the association of BARC-defined bleeding with mortality and compared its prognostic value against two validated bleeding scales: the Thrombolysis in Myocardial Infarction (TIMI) and the Global Utilization of… CONTINUE READING